ArticleThe oncologist2024

Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.

Kyoo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.